Literature DB >> 14520206

The clinical use of karyotyping spontaneous abortions.

W Allen Hogge1, Abigail L Byrnes, Mark C Lanasa, Urvashi Surti.   

Abstract

OBJECTIVE: The objective of this study was to assess the clinical use of routinely karyotyping spontaneous abortion material. STUDY
DESIGN: We retrospectively reviewed the records of the Pittsburgh Cytogenetics Laboratory from January 1, 1998, to December 31, 2001, for all tissues from spontaneous losses at 20 weeks' gestation or less for which complete medical records were available.
RESULTS: There were 517 submitted samples of which 28 (5.4%) failed to grow in culture. Overall, 55.8% of samples were abnormal; 52.3% of normal results were male. In samples from pregnancies at 13 weeks or less the rate of abnormality was 69.1%. When analyzed by maternal age, the rate of abnormality for first-trimester losses was 57.2% in women younger than 35 years, and 82.3% in those 35 years or older. There was no difference in the rate of abnormality when comparing first loss with two or more losses, first pregnancy with two or more pregnancies, or the presence or absence of at least one live birth.
CONCLUSION: Chromosome abnormalities are the cause for pregnancy loss in 50% to 80% of cases, depending on maternal age and gestational age at time of the loss. Karyotyping of spontaneous losses in the first trimester beginning with the patient's second loss provides clinically important etiologic information and decreases the number of evaluations necessary for recurrent pregnancy loss.

Entities:  

Mesh:

Year:  2003        PMID: 14520206     DOI: 10.1067/s0002-9378(03)00700-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Detection of thrombophilic mutations related to spontaneous abortions by a multiplex SNaPshot method.

Authors:  Svetlana Madjunkova; Marija Volk; Borut Peterlin; Dijana Plaseska-Karanfilska
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-24

2.  Cytogenetic testing of anembryonic pregnancies compared to embryonic missed abortions.

Authors:  Ruth B Lathi; Sara D Mark; Lynn M Westphal; Amin A Milki
Journal:  J Assist Reprod Genet       Date:  2007-09-27       Impact factor: 3.412

3.  Evaluation of chromosomal abnormalities and common trombophilic mutations in cases with recurrent miscarriage.

Authors:  Ahmet Karatas; Recep Eroz; Mustafa Albayrak; Tulay Ozlu; Bulent Cakmak; Fatih Keskin
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

4.  Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors.

Authors:  Mercy Y Laurino; Robin L Bennett; Devki S Saraiya; Lisa Baumeister; Debra Lochner Doyle; Kathleen Leppig; Barbara Pettersen; Robert Resta; Larry Shields; Stefanie Uhrich; Elizabeth A Varga; Wendy H Raskind
Journal:  J Genet Couns       Date:  2005-06       Impact factor: 2.537

Review 5.  Genetic considerations in recurrent pregnancy loss.

Authors:  Kassie J Hyde; Danny J Schust
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-06       Impact factor: 6.915

Review 6.  Recurrent pregnancy loss: fewer chromosomal abnormalities in products of conception? a meta-analysis.

Authors:  Dan Lei; Xin-Yu Zhang; Peng-Sheng Zheng
Journal:  J Assist Reprod Genet       Date:  2022-02-19       Impact factor: 3.412

7.  Association of recurrent pregnancy loss with chromosomal abnormalities and hereditary thrombophilias.

Authors:  Z Ocak; T Özlü; O Ozyurt
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

Review 8.  Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice?

Authors:  Adel Abu-Heija
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

9.  Exome sequencing links CEP120 mutation to maternally derived aneuploid conception risk.

Authors:  Katarzyna M Tyc; Warif El Yakoubi; Aishee Bag; Jessica Landis; Yiping Zhan; Nathan R Treff; Richard T Scott; Xin Tao; Karen Schindler; Jinchuan Xing
Journal:  Hum Reprod       Date:  2020-09-01       Impact factor: 6.918

10.  Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance.

Authors:  Pratip Chakraborty; S K Goswami; Shweta Rajani; Sunita Sharma; Syed N Kabir; Baidyanath Chakravarty; Kuladip Jana
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.